Novel RP-HPLC method for simultaneous determination of dapagliflozin and teneligliptin in tablet formulation and identification of degradation products by LC-MS/MS

• Autori principali: Thummar Kashyap (Autore), Kevat Honey (Autore), Vadher Priyanka (Autore), Jesur Mihir (Autore)
• Natura: Libro
• Pubblicazione: SpringerOpen, 2024-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Diabetes mellitus affects millions globally, necessitating effective management strategies. Glenmark Pharmaceutical Limited introduced a fixed-dose combination of teneligliptin and dapagliflozin in 2022 to address this need. However, existing methods for their simultaneous detect...